Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Affluent Medical SA ( (FR:AFME) ) is now available.
Affluent Medical has disclosed the number of shares and voting rights as of January 31, 2025, which includes 39,348,185 shares and 55,576,930 theoretical voting rights. The announcement provides transparency for stakeholders regarding the company’s capital structure and aligns with regulatory requirements.
More about Affluent Medical SA
Affluent Medical is a French medical technology company focused on developing innovative treatments for structural heart diseases and urinary incontinence. Founded by Truffle Capital, the company aims to become a global leader by offering new generation, minimally invasive implants that are undergoing clinical trials, with plans for market entry in 2026.
YTD Price Performance: 5.56%
Average Trading Volume: 1,166
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €54.07M
For an in-depth examination of AFME stock, go to TipRanks’ Stock Analysis page.